INTELLIA THERAPEUTICS INC's ticker is NTLA and the CUSIP is 45826J105. A total of 130 filers reported holding INTELLIA THERAPEUTICS INC in Q1 2018. The put-call ratio across all filers is 2.17 and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $747 | +0.8% | 23,649 | +31.0% | 0.00% | 0.0% |
| Q2 2023 | $741 | +3.3% | 18,057 | -6.0% | 0.00% | 0.0% |
| Q1 2023 | $717 | +30.1% | 19,207 | +22.3% | 0.00% | +100.0% |
| Q4 2022 | $551 | -99.9% | 15,709 | +64.4% | 0.00% | -50.0% |
| Q3 2022 | $534,000 | +200.0% | 9,555 | +176.7% | 0.00% | – |
| Q2 2022 | $178,000 | -32.6% | 3,453 | +1.1% | 0.00% | -100.0% |
| Q1 2022 | $264,000 | -35.1% | 3,417 | -1.0% | 0.00% | 0.0% |
| Q4 2021 | $407,000 | -11.9% | 3,453 | +1.0% | 0.00% | 0.0% |
| Q3 2021 | $462,000 | -16.5% | 3,420 | 0.0% | 0.00% | 0.0% |
| Q2 2021 | $553,000 | +140.4% | 3,420 | +18.5% | 0.00% | 0.0% |
| Q1 2021 | $230,000 | +24.3% | 2,887 | -15.4% | 0.00% | – |
| Q4 2020 | $185,000 | +293.6% | 3,411 | +42.8% | 0.00% | – |
| Q3 2020 | $47,000 | -6.0% | 2,388 | 0.0% | 0.00% | – |
| Q2 2020 | $50,000 | +72.4% | 2,388 | 0.0% | 0.00% | – |
| Q1 2020 | $29,000 | -17.1% | 2,388 | 0.0% | 0.00% | – |
| Q4 2019 | $35,000 | -52.1% | 2,388 | -46.9% | 0.00% | – |
| Q2 2019 | $73,000 | -5.2% | 4,500 | 0.0% | 0.00% | – |
| Q1 2019 | $77,000 | +30.5% | 4,500 | 0.0% | 0.00% | – |
| Q4 2018 | $59,000 | -95.4% | 4,500 | -90.0% | 0.00% | -100.0% |
| Q3 2018 | $1,296,000 | -51.1% | 45,110 | -53.5% | 0.00% | -50.0% |
| Q2 2018 | $2,652,000 | +32.9% | 97,031 | +2.5% | 0.01% | +20.0% |
| Q1 2018 | $1,995,000 | +7288.9% | 94,636 | +6659.7% | 0.01% | – |
| Q4 2017 | $27,000 | -20.6% | 1,400 | 0.0% | 0.00% | – |
| Q3 2017 | $34,000 | +54.5% | 1,400 | 0.0% | 0.00% | – |
| Q2 2017 | $22,000 | +10.0% | 1,400 | 0.0% | 0.00% | – |
| Q1 2017 | $20,000 | +11.1% | 1,400 | 0.0% | 0.00% | – |
| Q4 2016 | $18,000 | – | 1,400 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| HIMENSION CAPITAL (SINGAPORE) PTE. LTD. | 744,160 | $54,078,000 | 5.79% |
| Discovery Value Fund | 986,173 | $71,665,000 | 5.28% |
| Ally Bridge Group (NY) LLC | 60,000 | $4,360,000 | 3.23% |
| MPM BioImpact LLC | 159,409 | $11,584,000 | 3.11% |
| ARK Investment Management | 8,981,029 | $652,651,000 | 2.72% |
| Elmwood Wealth Management, Inc. | 67,599 | $4,912,000 | 2.52% |
| Nikko Asset Management Americas, Inc. | 2,872,269 | $192,442,000 | 1.41% |
| Frazier Life Sciences Management, L.P. | 203,684 | $14,802,000 | 1.26% |
| REGENTS OF THE UNIVERSITY OF CALIFORNIA | 111,440 | $8,098,000 | 1.22% |
| Merlin Capital, Inc | 11,575 | $841,000 | 1.11% |